Regis was awarded an SBIR Grant from National Institutes of Health Small Business Technology Transfer program

Regis was awarded an SBIR Grant from National Institutes of Health Small Business Technology Transfer program. Dr. Lukasz Ciesla uses Regis’s Immobilized Artificial Membrane (IAM) column for his Cellular Membrane Affinity Chromatography (CMAC) research. CMAC technology immobilizes target trans-membrane proteins onto a stationary phase. This lets the researcher identify the molecules in natural samples that interact with these proteins, allowing researchers to also understand the interaction.  Partnership to Develop Kit to Discover Drugs From Natural Sources – University of Alabama News | The University of Alabama (ua.edu)

1904054, lukasz ciesla lab